Alloy Therapeutics vs BioLegend
Alloy Therapeutics vs BioLegend, compared side by side on 10 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alloy Therapeutics is on 51/100 and BioLegend on Not scored yet.
Where each one leads
Alloy Therapeutics
Leads on none of the measures we hold for both companies.
BioLegend
- agent readiness: 51/100 against 39/100
- domain rating: 65/100 against 47/100
At a glance
| Measure | Alloy Therapeutics | BioLegend |
|---|---|---|
| What it is | A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services. | Developer and manufacturer of antibodies and reagents for biomedical research. |
| Category | Biotechnology, Artificial Intelligence, Drug Discovery, Drug Development | Biotechnology, Life Sciences, Discovery Tools, Antibodies |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software | hardware | services | marketplace | platform |
| Founded | 2017 | 2002 |
| Headquarters | Boston, USA | San Diego, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Alloy Therapeutics | BioLegend |
|---|---|---|
| Employees | Not published | 660 |
| Total funding | $157M | Not published |
| Latest round | Series E | Not published |
| Valuation | $1.0B | Not published |
| LinkedIn followers | Not published | 27,014 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alloy Therapeutics | BioLegend |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | Not published |
| Traction | 40/100 | Not published |
| Team | 30/100 | Not published |
| Search visibility | 15/100 | Not published |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (51/100) |
| Domain ratingLink authority, 0-100 | 47/100 | 65/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alloy Therapeutics | BioLegend |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
| Support stack | HubSpot | Not detected |
Alloy Therapeutics vs BioLegend: common questions
Which is better, Alloy Therapeutics or BioLegend?
On our 0-100 score Alloy Therapeutics rates higher (51/100 against Not scored yet). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 10 data points above: read the rows that match what you are buying for.
How do Alloy Therapeutics and BioLegend compare on the numbers?
BioLegend leads on agent readiness (51/100 against 39/100), domain rating (65/100 against 47/100).
Read the full Alloy Therapeutics review and pricing or the BioLegend review and pricing. You can also browse other Alloy Therapeutics alternatives we track.

